NasdaqGS - Nasdaq Real Time Price USD

United Therapeutics Corporation (UTHR)

Time to buy UTHR?

315.64

+0.80

+(0.25%)

At close: May 28 at 4:00:00 PM EDT

315.50

-0.14

(-0.04%)

After hours: May 28 at 7:16:53 PM EDT

Time to buy UTHR?

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.

StockStory yesterday

MYGN

BMRN

UTHR
+0.25%
1 Safe-and-Steady Stock on Our Buy List and 2 to Ignore

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

StockStory 9 days ago

CHD

UTHR
+0.25%

FIGS
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including United Therapeutics (NASDAQ:UTHR) and its peers.

StockStory 14 days ago

UTHR
+0.25%

ABBV

SRPT
UTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains Central

Biotechnology company United Therapeutics (NASDAQ:UTHR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 17.2% year on year to $794.4 million. Its non-GAAP profit of $7.28 per share was 11.3% above analysts’ consensus estimates.

StockStory 15 days ago

UTHR
+0.25%
Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and […]

Insider Monkey 17 days ago

UTHR
+0.25%
Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...

Despite financial challenges, Liquidia Corp (LQDA) is poised for growth with its upcoming product launch and favorable legal outcomes.

GuruFocus.com 19 days ago

LQDA

UTHR
+0.25%
3 Big Reasons to Love United Therapeutics (UTHR)

What a brutal six months it’s been for United Therapeutics. The stock has dropped 23.1% and now trades at $308, rattling many shareholders. This might have investors contemplating their next move.

StockStory 19 days ago

UTHR
+0.25%
Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex Pharmaceuticals (NASDAQ:VRTX).

StockStory 19 days ago

VRTX

UTHR
+0.25%

ABBV
Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT)

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Sarepta Therapeutics (NASDAQ:SRPT).

StockStory 20 days ago

SRPT

BMRN

UTHR
+0.25%
3 Market-Beating Stocks with Solid Fundamentals

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.

StockStory 21 days ago

PLTR

UTHR
+0.25%
Earnings To Watch: Sarepta Therapeutics (SRPT) Reports Q1 Results Tomorrow

Biotech company Sarepta Therapeutics (NASDAQ:SRPT) will be reporting results tomorrow after market hours. Here’s what to look for.

StockStory 23 days ago

SRPT

BMRN

UTHR
+0.25%
United Therapeutics First Quarter 2025 Earnings: Beats Expectations

United Therapeutics ( NASDAQ:UTHR ) First Quarter 2025 Results Key Financial Results Revenue: US$794.4m (up 17% from 1Q...

Simply Wall St. 26 days ago

UTHR
+0.25%
UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales

United Therapeutics reports better-than-expected first-quarter 2025 results, beating both earnings and revenue estimates, driven mainly by strong Tyvaso sales.

Zacks 27 days ago

UTHR
+0.25%
United Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

United Therapeutics Corp (UTHR) reports a robust quarter with record revenue and strategic initiatives, while navigating competitive pressures and clinical trial challenges.

GuruFocus.com 27 days ago

UTHR
+0.25%
1 Value Stock Worth Investigating and 2 to Brush Off

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

StockStory 27 days ago

LZ

ZBH

UTHR
+0.25%
United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for United Therapeutics (UTHR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 28 days ago

UTHR
+0.25%
United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates

United Therapeutics (UTHR) delivered earnings and revenue surprises of 5.41% and 9.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 28 days ago

UTHR
+0.25%
United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1

Biotechnology company United Therapeutics (NASDAQ:UTHR) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 17.2% year on year to $794.4 million. Its GAAP profit of $6.63 per share was 5.1% above analysts’ consensus estimates.

StockStory 28 days ago

UTHR
+0.25%
United Therapeutics: Q1 Earnings Snapshot

SILVER SPRING, Md. AP) — United Therapeutics Corp. UTHR) on Wednesday reported first-quarter profit of $322.2 million.

Associated Press Finance 28 days ago

UTHR
+0.25%
United Therapeutics Corporation Reports First Quarter 2025 Financial Results

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 30, 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31, 2025. Total revenues in the first quarter of 2025 grew 17 percent year-over-year to $794.4 million, compared to $677.7 million in the first quarter of 2024.

Business Wire 28 days ago

UTHR
+0.25%

Performance Overview

Return	UTHR	S&P 500 (^GSPC)
YTD	-10.54%	+0.12%
1-Year	+17.27%	+10.98%
3-Year	+33.84%	+41.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

United Therapeutics Corporation (UTHR)

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

1 Safe-and-Steady Stock on Our Buy List and 2 to Ignore

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

UTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains Central

Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ...

3 Big Reasons to Love United Therapeutics (UTHR)

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT)

3 Market-Beating Stocks with Solid Fundamentals

Earnings To Watch: Sarepta Therapeutics (SRPT) Reports Q1 Results Tomorrow

United Therapeutics First Quarter 2025 Earnings: Beats Expectations

UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales

United Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

1 Value Stock Worth Investigating and 2 to Brush Off

United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say

United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates

United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1

United Therapeutics: Q1 Earnings Snapshot

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

Performance Overview